Monopar Therapeutics Inc. (MNPR)
NASDAQ · Healthcare
Monopar Therapeutics Inc. Revenue 2016–2025
Monopar Therapeutics Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Monopar Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0.
- Monopar Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 0.
- Monopar Therapeutics Inc. annual revenue for 2025 was 0.
- Monopar Therapeutics Inc. annual revenue for 2024 was 0.
- Monopar Therapeutics Inc. annual revenue for 2019 was 0.
- Monopar Therapeutics Inc. annual revenue for 2018 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
Monopar Therapeutics Inc. (MNPR) — Frequently Asked Questions
Monopar Therapeutics Inc. (MNPR) is a publicly traded US company. It has a market capitalization of $394M. Explore MNPR's stock price, financial statements, earnings history, margins and key ratios below.
What is Monopar Therapeutics Inc.'s market cap?
Monopar Therapeutics Inc. (MNPR) has a market capitalization of $394M.
What is the MNPR stock price?
MNPR trades at $58.87 (-0.93% on the day).
Is MNPR profitable?
In fiscal 2025, Monopar Therapeutics Inc. reported net income of -$14M.